Form 8-K · Current report
Arch Capital Group 8-K, filed Oct 30, 2026
- Filed
- CIK
- 0000947484
- Accession no.
- 0000947484-26-000138
Summary
Arch Reinsurance Ltd., a wholly-owned subsidiary of Arch Capital Group Ltd., entered into Amendment No. 6 to its letter of credit facility agreement with Lloyds Bank Corporate Markets plc as administrative and L/C agent, extending the letters of credit for the 2027 underwriting year, moving the last day of the availability period from May 31, 2026 to May 31, 2027, and raising the maximum incremental commitment from $50 million to $200 million under the $700 million facility.
Key points
- The amendment was entered into on October 28, 2026, and the 8-K was filed October 30, 2026.
- The existing agreement dates from November 3, 2020 and had been amended five times previously, most recently on October 29, 2025.
- The amended facility provides $700 million for letters of credit.
- Portions of the filed exhibit were omitted under Regulation S-K confidentiality provisions.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 1.01Entry into a Material Definitive Agreement
- 2.03Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 9.01Financial Statements and Exhibits
From the filing
ITEM 1.01 Entry into a Material Definitive Agreement. On October 28, 2026, Arch Reinsurance Ltd. (“ArchRe”), a wholly-owned subsidiary of Arch Capital Group Ltd. (“Arch”), entered into Amendment No. 6 to Letter of Credit Facility Agreement (“Amendment No. 6”), as the borrower with Lloyds Bank Corporate Markets plc (“Lloyds”), as Administrative Agent and L/C Agent, which amends the Letter of Credit Facility Agreement, dated as of November 3, 2020, as amended by Amendment No. 1 to Letter of Credit Facility Agreement dated as of October 29, 2021, as further amended by Amendment No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.